Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-22T19:33:01.563Z Has data issue: false hasContentIssue false

A Clinical Trial of Stemetil (Prochlorperazine)

Published online by Cambridge University Press:  08 February 2018

Hugo B. Milne
Affiliation:
Pastures Hospital, Mickleover, Derby
Fritz Berliner
Affiliation:
Pastures Hospital, Mickleover, Derby

Extract

Phenothiazine derivatives have been widely employed in the management of schizophrenia over the past few years. Possibly the most commonly used has been chlorpromazine under its trade name “Largactil”.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1958 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Baker, A. A., and Thorpe, J. G., “Deteriorated Psychotic Patients—their Treatment and its Assessment”, J. Ment. Sci., 1956, 102, 780789.CrossRefGoogle Scholar
2. Broussolle, P., and Dubor, P., “Preliminary Appraisal of the Clinical Effects of a New Neuroleptic”, Congr. Alién, Neurol., Bordeaux, 1956.Google Scholar
3. Ducrot, R., and Koetschet, P., “Anti-emetic Properties of a New Phenothiazine Derivative 3-Chloro-10-(3-N-methyl-piperazinylpropyl)-phenothiazine (6140 R.P.)”, Int. Physiol. Congr., Brussels, 1956.Google Scholar
4. Smithy, G., and Homburger, F., “Prochlorperazine for the Treatment of Nausea and Vomiting in Patients with Advanced Cancer and other Chronic Diseases”, New Eng. J. Med., 1957, 256, 27.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.